Monograph Details

Endocrine System > Diabetes
HUMALOG
Manufacturer
Lilly, Eli and Company
Legal Classification
Rx
Generic Name
Insulin lispro (recombinant) 100 Units/mL; soln for SC inj; contains zinc, m-cresol.
Also
HUMALOG MIX50/50
HUMALOG MIX75/25
Indications
Diabetes.
Adults and Children
≤3yrs: not recommended. >3yrs: SC injection only. Onset approx ≤15 minutes, peak approx 1 hr, duration approx 3.5–4.5 hrs.
Precautions
Instruct patients on diet, exercise, blood or urine testing, proper administration of insulin, change in species of origin, type or purity of insulin, and management of hypoglycemia. Dosage increase may be required during infection, illness, stress, trauma, and pregnancy. Dosage decrease may be needed with renal or hepatic dysfunction. Pregnancy (Cat.B). Nursing mothers.
Interactions
Potentiated by salicylates, MAOIs, alcohol, sulfa drugs, some ACE inhibitors, drugs that inhibit pancreatic function (eg, octreotide). Antagonized by corticosteroids, isoniazid, niacin, thiazides, phenothiazines, sympathomimetics. Variable effects with β-blockers, clonidine, lithium salts, alcohol. When mixing insulin lispro with other insulins, draw insulin lispro into syringe first and inject mixture immediately.
Adverse Reactions
Hypoglycemia, hypokalemia, local or systemic allergy, lipodystrophy, edema.
How Supplied
Humalog Mix75/25, Humalog vials (10mL)—1
Humalog Mix, Humalog prefilled disposable pens—5x3mL
Humalog Mix, Humalog KwikPen (disposable insulin delivery device) (3mL)—5
Humalog cartridges (3mL)—5
HumaPen MEMOIR (inj device, uses Humalog cartridges)—1
HumaPen LUXURA HD (inj device, uses Humalog cartridges)—1
Additional Resources
Related Prescribing Note